{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:28:03Z","timestamp":1793924883877,"version":"4.8.0"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s40272-026-00777-y","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:17:42Z","timestamp":1792102662000},"page":"619-636","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacological Interventions for Acute Stress Disorder and for the Prevention and Treatment of Post-traumatic Stress Disorder in Children and Adolescents: A Narrative Review"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8368-7913","authenticated-orcid":false,"given":"Charles","family":"Tesni\u00e8res","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5509-6471","authenticated-orcid":false,"given":"Hala","family":"Kerbage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1413-6473","authenticated-orcid":false,"given":"Eric","family":"Bui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4066-8438","authenticated-orcid":false,"given":"Julie","family":"Rolling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"key":"777_CR1","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1037\/tra0000371","volume":"11","author":"D Darnell","year":"2019","unstructured":"Darnell D, Flaster A, Hendricks K, Kerbrat A, Comtois KA. Adolescent clinical populations and associations between trauma and behavioral and emotional problems. Psychol Trauma. 2019;11:266\u201373. https:\/\/doi.org\/10.1037\/tra0000371.","journal-title":"Psychol Trauma"},{"key":"777_CR2","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.jaac.2013.05.011","volume":"52","author":"KA McLaughlin","year":"2013","unstructured":"McLaughlin KA, Koenen KC, Hill ED, Petukhova M, Sampson NA, Zaslavsky AM, et al. Trauma exposure and posttraumatic stress disorder in a national sample of adolescents. J Am Acad Child Adolesc Psychiatry. 2013;52:815-30.e14. https:\/\/doi.org\/10.1016\/j.jaac.2013.05.011.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"777_CR3","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1017\/S0033291717000708","volume":"47","author":"KC Koenen","year":"2017","unstructured":"Koenen KC, Ratanatharathorn A, Ng L, McLaughlin KA, Bromet EJ, Stein DJ, et al. Posttraumatic stress disorder in the World Mental Health Surveys. Psychol Med. 2017;47:2260\u201374. https:\/\/doi.org\/10.1017\/S0033291717000708.","journal-title":"Psychol Med"},{"key":"777_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S2215-0366(19)30031-8","volume":"6","author":"SJ Lewis","year":"2019","unstructured":"Lewis SJ, Arseneault L, Caspi A, Fisher HL, Matthews T, Moffitt TE, et al. The epidemiology of trauma and post-traumatic stress disorder in a representative cohort of young people in England and Wales. Lancet Psychiatry. 2019;6:247\u201356. https:\/\/doi.org\/10.1016\/S2215-0366(19)30031-8.","journal-title":"Lancet Psychiatry"},{"key":"777_CR5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1034\/j.1600-0447.2000.101001046.x","volume":"101","author":"A Perkonigg","year":"2000","unstructured":"Perkonigg A, Kessler RC, Storz S, Wittchen H. Traumatic events and post\u2010traumatic stress disorder in the community: prevalence,risk factors and comorbidity. Acta Psychiatr Scand. 2000;101:46\u201359. https:\/\/doi.org\/10.1034\/j.1600-0447.2000.101001046.x.","journal-title":"Acta Psychiatr Scand"},{"key":"777_CR6","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1192\/bjp.bp.113.131227","volume":"204","author":"E Alisic","year":"2014","unstructured":"Alisic E, Zalta AK, Van Wesel F, Larsen SE, Hafstad GS, Hassanpour K, et al. Rates of post-traumatic stress disorder in trauma-exposed children and adolescents: meta-analysis. Br J Psychiatry. 2014;204:335\u201340. https:\/\/doi.org\/10.1192\/bjp.bp.113.131227.","journal-title":"Br J Psychiatry"},{"key":"777_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-017-0825-3","volume":"19","author":"RJ Herringa","year":"2017","unstructured":"Herringa RJ. Trauma, PTSD, and the developing brain. Curr Psychiatry Rep. 2017;19:69. https:\/\/doi.org\/10.1007\/s11920-017-0825-3.","journal-title":"Curr Psychiatry Rep"},{"key":"777_CR8","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1097\/01.TA.0000159247.48547.7D","volume":"58","author":"TL Holbrook","year":"2005","unstructured":"Holbrook TL, Hoyt DB, Coimbra R, Potenza B, Sise M, Anderson JP. Long-term posttraumatic stress disorder persists after major trauma in adolescents: new data on risk factors and functional outcome. J Trauma. 2005;58:764\u201371. https:\/\/doi.org\/10.1097\/01.TA.0000159247.48547.7D.","journal-title":"J Trauma"},{"key":"777_CR9","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1192\/bjp.182.6.532","volume":"182","author":"L Morgan","year":"2003","unstructured":"Morgan L, Scourfield J, Williams D, Jasper A, Lewis G. The Aberfan disaster: 33-year follow-up of survivors. Br J Psychiatry. 2003;182:532\u20136. https:\/\/doi.org\/10.1192\/bjp.182.6.532.","journal-title":"Br J Psychiatry"},{"key":"777_CR10","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/1469-7610.00635","volume":"41","author":"W Yule","year":"2000","unstructured":"Yule W, Bolton D, Udwin O, Boyle S, O\u2019Ryan D, Nurrish J. The long-term psychological effects of a disaster experienced in adolescence: I. The incidence and course of PTSD. J Child Psychol Psychiat. 2000;41:503\u201311.","journal-title":"J Child Psychol Psychiat"},{"key":"777_CR11","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.21m14116","volume":"83","author":"LL Davis","year":"2022","unstructured":"Davis LL, Schein J, Cloutier M, Gagnon-Sanschagrin P, Maitland J, Urganus A, et al. The economic burden of posttraumatic stress disorder in the United States from a societal perspective. J Clin Psychiatry. 2022;83:21m14116. https:\/\/doi.org\/10.4088\/JCP.21m14116.","journal-title":"J Clin Psychiatry"},{"key":"777_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13034-025-00879-4","volume":"19","author":"TT Tamir","year":"2025","unstructured":"Tamir TT, Tekeba B, Mekonen EG, Gebrehana DA, Zegeye AF. Shadows of trauma: an umbrella review of the prevalence and risk factors of post-traumatic stress disorder in children and adolescents. Child Adolesc Psychiatry Ment Health. 2025;19:48. https:\/\/doi.org\/10.1186\/s13034-025-00879-4.","journal-title":"Child Adolesc Psychiatry Ment Health"},{"key":"777_CR13","unstructured":"International Society For Traumatic Stress Studies. ISTSS guidelines position paper on complex PTSD in children and adolescents. 2024. https:\/\/istss.org\/wp-content\/uploads\/2024\/08\/ISTSS-Guidelines-Position-Paper-on-Complex-PTSD-in-Children-and-Adolescents.pdf. Accessed 6 Sept 2026."},{"key":"777_CR14","unstructured":"National Institute for Health and Care Excellence (NICE). Post-traumatic stress disorder. London; National Institute for Health and Care Excellence (NICE); 2018. www.nice.org.uk\/guidance\/ng116. Accessed 6 Sept 2026."},{"key":"777_CR15","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1177\/00048674211041917","volume":"56","author":"AJ Phelps","year":"2022","unstructured":"Phelps AJ, Lethbridge R, Brennan S, Bryant RA, Burns P, Cooper JA, et al. Australian guidelines for the prevention and treatment of posttraumatic stress disorder: updates in the third edition. Aust N Z J Psychiatry. 2022;56:230\u201347. https:\/\/doi.org\/10.1177\/00048674211041917.","journal-title":"Aust N Z J Psychiatry"},{"key":"777_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0145-2134(00)00226-X","volume":"25","author":"JA Cohen","year":"2001","unstructured":"Cohen JA, Mannarino AP, Rogal S. Treatment practices for childhood posttraumatic stress disorder. Child Abuse Negl. 2001;25:123\u201335. https:\/\/doi.org\/10.1016\/S0145-2134(00)00226-X.","journal-title":"Child Abuse Negl"},{"key":"777_CR17","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/jts.21683","volume":"25","author":"JF Havens","year":"2012","unstructured":"Havens JF, Gudi\u00f1o OG, Biggs EA, Diamond UN, Weis JR, Cloitre M. Identification of trauma exposure and PTSD in adolescent psychiatric inpatients: an exploratory study. J Trauma Stress. 2012;25:171\u20138. https:\/\/doi.org\/10.1002\/jts.21683.","journal-title":"J Trauma Stress"},{"key":"777_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-019-0673-5","volume":"9","author":"L Astill Wright","year":"2019","unstructured":"Astill Wright L, Sijbrandij M, Sinnerton R, Lewis C, Roberts NP, Bisson JI. Pharmacological prevention and early treatment of post-traumatic stress disorder and acute stress disorder: a systematic review and meta-analysis. Transl Psychiatry. 2019;9:334. https:\/\/doi.org\/10.1038\/s41398-019-0673-5.","journal-title":"Transl Psychiatry"},{"key":"777_CR19","doi-asserted-by":"publisher","DOI":"10.7812\/TPP\/18.300","volume":"23","author":"LM Bolsoni","year":"2019","unstructured":"Bolsoni LM, Da Silva TDA, Quintana SM, De Castro M, Crippa JA, Zuardi AW. Changes in cortisol awakening response before and after development of posttraumatic stress disorder, which cannot be avoided with use of cannabidiol: a case report. Perm J. 2019;23:18.300. https:\/\/doi.org\/10.7812\/TPP\/18.300.","journal-title":"Perm J"},{"key":"777_CR20","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.nlm.2014.02.001","volume":"112","author":"B Hruska","year":"2014","unstructured":"Hruska B, Cullen PK, Delahanty DL. Pharmacological modulation of acute trauma memories to prevent PTSD: considerations from a developmental perspective. Neurobiol Learn Mem. 2014;112:122\u20139. https:\/\/doi.org\/10.1016\/j.nlm.2014.02.001.","journal-title":"Neurobiol Learn Mem"},{"key":"777_CR21","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/jts.20517","volume":"23","author":"NR Nugent","year":"2010","unstructured":"Nugent NR, Christopher NC, Crow JP, Browne L, Ostrowski S, Delahanty DL. The efficacy of early propranolol administration at reducing PTSD symptoms in pediatric injury patients: a pilot study. J Trauma Stress. 2010;23:282\u20137. https:\/\/doi.org\/10.1002\/jts.20517.","journal-title":"J Trauma Stress"},{"key":"777_CR22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1089\/cap.2017.0073","volume":"28","author":"L Rosenberg","year":"2018","unstructured":"Rosenberg L, Rosenberg M, Sharp S, Thomas CR, Humphries HF, Holzer CE, et al. Does acute propranolol treatment prevent posttraumatic stress disorder, anxiety, and depression in children with burns? J Child Adolesc Psychopharmacol. 2018;28:117\u201323. https:\/\/doi.org\/10.1089\/cap.2017.0073.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"777_CR23","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1097\/00004583-200108000-00013","volume":"40","author":"G Saxe","year":"2001","unstructured":"Saxe G, Stoddard F, Courtney D, Cunningham K, Chawla N, Sheridan R, et al. Relationship between acute morphine and the course of PTSD in children with burns. J Am Acad Child Adolesc Psychiatry. 2001;40:915\u201321. https:\/\/doi.org\/10.1097\/00004583-200108000-00013.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"777_CR24","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1097\/TA.0b013e3182ab111c","volume":"76","author":"RL Sheridan","year":"2014","unstructured":"Sheridan RL, Stoddard FJ, Kazis LE, Lee A, Li N-C, Kagan RJ, et al. Long-term posttraumatic stress symptoms vary inversely with early opiate dosing in children recovering from serious burns: effects durable at 4 years. J Trauma Acute Care Surg. 2014;76:828\u201332. https:\/\/doi.org\/10.1097\/TA.0b013e3182ab111c.","journal-title":"J Trauma Acute Care Surg"},{"key":"777_CR25","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1097\/BCR.0b013e3181b48102","volume":"30","author":"FJ Stoddard","year":"2009","unstructured":"Stoddard FJ, Sorrentino EA, Ceranoglu TA, Saxe G, Murphy JM, Drake JE, et al. Preliminary evidence for the effects of morphine on posttraumatic stress disorder symptoms in one- to four-year-olds with burns. J Burn Care Res. 2009;30:836\u201343. https:\/\/doi.org\/10.1097\/BCR.0b013e3181b48102.","journal-title":"J Burn Care Res"},{"key":"777_CR26","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1089\/cap.2010.0133","volume":"21","author":"FJ Stoddard","year":"2011","unstructured":"Stoddard FJ, Luthra R, Sorrentino EA, Saxe GN, Drake J, Chang Y, et al. A randomized controlled trial of sertraline to prevent posttraumatic stress disorder in burned children. J Child Adolesc Psychopharmacol. 2011;21:469\u201377. https:\/\/doi.org\/10.1089\/cap.2010.0133.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"777_CR27","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1097\/00004583-199907000-00018","volume":"38","author":"R Robert","year":"1999","unstructured":"Robert R, Blakeney PE, Villarreal C, Rosenberg L, Meyer WJ. Imipramine treatment in pediatric burn patients with symptoms of acute stress disorder: a pilot study. J Am Acad Child Adolesc Psychiatry. 1999;38:873\u201382. https:\/\/doi.org\/10.1097\/00004583-199907000-00018.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"777_CR28","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/s10578-010-0192-3","volume":"41","author":"J Huemer","year":"2010","unstructured":"Huemer J, Erhart F, Steiner H. Posttraumatic stress disorder in children and adolescents: a review of psychopharmacological treatment. Child Psychiatry Hum Dev. 2010;41:624\u201340. https:\/\/doi.org\/10.1007\/s10578-010-0192-3.","journal-title":"Child Psychiatry Hum Dev"},{"key":"777_CR29","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1089\/cap.2006.0121","volume":"17","author":"KG Meighen","year":"2007","unstructured":"Meighen KG, Hines LA, Lagges AM. Risperidone treatment of preschool children with thermal burns and acute stress disorder. J Child Adolesc Psychopharmacol. 2007;17:223\u201332. https:\/\/doi.org\/10.1089\/cap.2006.0121.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"777_CR30","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.burns.2008.04.009","volume":"34","author":"R Robert","year":"2008","unstructured":"Robert R, Tcheung WJ, Rosenberg L, Rosenberg M, Mitchell C, Villarreal C, et al. Treating thermally injured children suffering symptoms of acute stress with imipramine and fluoxetine: a randomized, double-blind study. Burns. 2008;34:919\u201328. https:\/\/doi.org\/10.1016\/j.burns.2008.04.009.","journal-title":"Burns"},{"key":"777_CR31","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/00004630-199905000-00017","volume":"30","author":"R Robert","year":"1999","unstructured":"Robert R, Meyer WJ, Villarreal C, Blakeney PE, Desai M, Herndon D. An approach of the timely treatment of acute stress disorder. J Burn Care Rehabil. 1999;30:250\u20138. https:\/\/doi.org\/10.1097\/00004630-199905000-00017.","journal-title":"J Burn Care Rehabil"},{"key":"777_CR32","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/TA.0b013e3181a8b326","volume":"68","author":"S Sharp","year":"2010","unstructured":"Sharp S, Thomas C, Rosenberg L, Rosenberg M, Meyer W. Propranolol does not reduce risk for acute stress disorder in pediatric burn trauma. J Trauma. 2010;68:193\u20137. https:\/\/doi.org\/10.1097\/TA.0b013e3181a8b326.","journal-title":"J Trauma"},{"key":"777_CR33","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1097\/01.PCC.0000165562.04157.DA","volume":"6","author":"WJ Tcheung","year":"2005","unstructured":"Tcheung WJ, Robert R, Rosenberg L, Rosenberg M, Villarreal C, Thomas C, et al. Early treatment of acute stress disorder in children with major burn injury. Pediatr Crit Care Med. 2005;6:676\u201381. https:\/\/doi.org\/10.1097\/01.PCC.0000165562.04157.DA.","journal-title":"Pediatr Crit Care Med"},{"key":"777_CR34","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1023\/A:1022851324044","volume":"16","author":"JA Cohen","year":"2003","unstructured":"Cohen JA, Berliner L, Mannarino AP. Psychosocial and pharmacological interventions for child crime victims. J Trauma Stress. 2003;16:175\u201386. https:\/\/doi.org\/10.1023\/A:1022851324044.","journal-title":"J Trauma Stress"},{"key":"777_CR35","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1056-4993(02)00102-5","volume":"12","author":"CL Donnelly","year":"2003","unstructured":"Donnelly CL. Pharmacologic treatment approaches for children and adolescents with posttraumatic stress disorder. Child Adolesc Psychiatr Clin N Am. 2003;12:251\u201369. https:\/\/doi.org\/10.1016\/S1056-4993(02)00102-5.","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"777_CR36","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1089\/cap.1999.9.203","volume":"9","author":"CL Donnelly","year":"1999","unstructured":"Donnelly CL, Amaya-Jackson L, March JS. Psychopharmacology of pediatric posttraumatic stress disorder. J Child Adolesc Psychopharmacol. 1999;9:203\u201320. https:\/\/doi.org\/10.1089\/cap.1999.9.203.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"777_CR37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jadohealth.2012.06.018","volume":"52","author":"R Gerson","year":"2013","unstructured":"Gerson R, Rappaport N. Traumatic stress and posttraumatic stress disorder in youth: recent research findings on clinical impact, assessment, and treatment. J Adolesc Health. 2013;52:137\u201343. https:\/\/doi.org\/10.1016\/j.jadohealth.2012.06.018.","journal-title":"J Adolesc Health"},{"key":"777_CR38","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s11920-008-0019-0","volume":"10","author":"F Najjar","year":"2008","unstructured":"Najjar F, Weller RA, Weisbrot J, Weller EB. Post-traumatic stress disorder and its treatment in children and adolescents. Curr Psychiatry Rep. 2008;10:104\u20138. https:\/\/doi.org\/10.1007\/s11920-008-0019-0.","journal-title":"Curr Psychiatry Rep"},{"key":"777_CR39","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/00008480-199908000-00008","volume":"11","author":"BD Perry","year":"1999","unstructured":"Perry BD, Azad I. Posttraumatic stress disorders in children and adolescents. Curr Opin Pediatr. 1999;11:310\u20136. https:\/\/doi.org\/10.1097\/00008480-199908000-00008.","journal-title":"Curr Opin Pediatr"},{"key":"777_CR40","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/MOP.0b013e32833e26d5","volume":"22","author":"M Stamatakos","year":"2010","unstructured":"Stamatakos M, Campo JV. Psychopharmacologic treatment of traumatized youth. Curr Opin Pediatr. 2010;22:599\u2013604. https:\/\/doi.org\/10.1097\/MOP.0b013e32833e26d5.","journal-title":"Curr Opin Pediatr"},{"key":"777_CR41","doi-asserted-by":"publisher","first-page":"932","DOI":"10.4088\/JCP.09r05446blu","volume":"71","author":"JR Strawn","year":"2010","unstructured":"Strawn JR, Keeshin BR, DelBello MP, Geracioti TD, Putnam FW. Psychopharmacologic treatment of posttraumatic stress disorder in children and adolescents: a review. J Clin Psychiatry. 2010;71:932\u201341. https:\/\/doi.org\/10.4088\/JCP.09r05446blu.","journal-title":"J Clin Psychiatry"},{"key":"777_CR42","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4102\/curationis.v26i2.782","volume":"26","author":"A Traut","year":"2003","unstructured":"Traut A, Cur M, Kaminer D, Psych M, Boshoff D, Ed D, et al. Treatment utilisation and trauma characteristics of child and adolescent inpatients with posttraumatic stress disorder. Curationis. 2003;26:44\u20138. https:\/\/doi.org\/10.4102\/curationis.v26i2.782.","journal-title":"Curationis"},{"key":"777_CR43","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1089\/cap.2009.0115","volume":"20","author":"AS Robb","year":"2010","unstructured":"Robb AS, Cueva JE, Sporn J, Yang R, Vanderburg DG. Sertraline treatment of children and adolescents with posttraumatic stress disorder: a double-blind, placebo-controlled trial. J Child Adolesc Psychopharmacol. 2010;20:463\u201371. https:\/\/doi.org\/10.1089\/cap.2009.0115.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"777_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.00717","volume":"11","author":"K Boaden","year":"2020","unstructured":"Boaden K, Tomlinson A, Cortese S, Cipriani A. Antidepressants in children and adolescents: meta-review of efficacy, tolerability and suicidality in acute treatment. Front Psychiatry. 2020;11:717. https:\/\/doi.org\/10.3389\/fpsyt.2020.00717.","journal-title":"Front Psychiatry"},{"key":"777_CR45","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1080\/15622975.2022.2086296","volume":"24","author":"B Bandelow","year":"2023","unstructured":"Bandelow B, Allgulander C, Baldwin DS, Costa DLDC, Denys D, Dilbaz N, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders\u2014version 3. Part II: OCD and PTSD. World J Biol Psychiatry. 2023;24:118\u201334. https:\/\/doi.org\/10.1080\/15622975.2022.2086296.","journal-title":"World J Biol Psychiatry"},{"key":"777_CR46","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.14.1837","volume":"283","author":"K Brady","year":"2000","unstructured":"Brady K, Pearlstein T, Asnis GM, Baker D, Rothbaum B, Sikes CR, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000;283:1837. https:\/\/doi.org\/10.1001\/jama.283.14.1837.","journal-title":"JAMA"},{"key":"777_CR47","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1001\/jamapsychiatry.2018.3412","volume":"76","author":"SAM Rauch","year":"2019","unstructured":"Rauch SAM, Kim HM, Powell C, Tuerk PW, Simon NM, Acierno R, et al. Efficacy of prolonged exposure therapy, sertraline hydrochloride, and their combination among combat veterans with posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiat. 2019;76:117\u201326. https:\/\/doi.org\/10.1001\/jamapsychiatry.2018.3412.","journal-title":"JAMA Psychiat"},{"key":"777_CR48","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/00004850-200101000-00002","volume":"16","author":"S Seedat","year":"2001","unstructured":"Seedat S, Lockhat R, Kaminer D, Zungu-Dirwayi N, Stein DJ. An open trial of citalopram in adolescents with post-traumatic stress disorder. Int Clin Psychopharmacol. 2001;16:21\u20135. https:\/\/doi.org\/10.1097\/00004850-200101000-00002.","journal-title":"Int Clin Psychopharmacol"},{"key":"777_CR49","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1089\/10445460252943551","volume":"12","author":"S Seedat","year":"2002","unstructured":"Seedat S, Stein DJ, Ziervogel C, Middleton T, Kaminer D, Emsley RA, et al. Comparison of response to a selective serotonin reuptake inhibitor in children, adolescents, and adults with posttraumatic stress disorder. J Child Adolesc Psychopharmacol. 2002;12:37\u201346. https:\/\/doi.org\/10.1089\/10445460252943551.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"777_CR50","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1097\/00004583-200008000-00003","volume":"39","author":"SE Domon","year":"2000","unstructured":"Domon SE, Andersen MS. Nefazodone for PTSD. J Am Acad Child Adolesc Psychiatry. 2000;39:942\u20133. https:\/\/doi.org\/10.1097\/00004583-200008000-00003.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"777_CR51","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1001\/jamapsychiatry.2017.2432","volume":"74","author":"C Locher","year":"2017","unstructured":"Locher C, Koechlin H, Zion SR, Werner C, Pine DS, Kirsch I, et al. Efficacy and safety of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and placebo for common psychiatric disorders among children and adolescents: a systematic review and meta-analysis. JAMA Psychiat. 2017;74:1011\u201320. https:\/\/doi.org\/10.1001\/jamapsychiatry.2017.2432.","journal-title":"JAMA Psychiat"},{"key":"777_CR52","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1097\/chi.0b013e3180547105","volume":"46","author":"JA Cohen","year":"2007","unstructured":"Cohen JA, Mannarino AP, Perel JM, Staron V. A pilot randomized controlled trial of combined trauma-focused CBT and sertraline for childhood PTSD symptoms. J Am Acad Child Adolesc Psychiatry. 2007;46:811\u20139. https:\/\/doi.org\/10.1097\/chi.0b013e3180547105.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"777_CR53","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s10578-007-0055-8","volume":"38","author":"H Steiner","year":"2007","unstructured":"Steiner H, Saxena KS, Carrion V, Khanzode LA, Silverman M, Chang K. Divalproex sodium for the treatment of PTSD and conduct disordered youth: a pilot randomized controlled clinical trial. Child Psychiatry Hum Dev. 2007;38:183\u201393. https:\/\/doi.org\/10.1007\/s10578-007-0055-8.","journal-title":"Child Psychiatry Hum Dev"},{"key":"777_CR54","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1097\/00004583-199506000-00008","volume":"34","author":"D Looff","year":"1995","unstructured":"Looff D, Grimley P, Kuller F, Martin A, Shonfield L. Carbamazepine for PTSD. J Am Acad Child Adolesc Psychiatry. 1995;34:703\u20134. https:\/\/doi.org\/10.1097\/00004583-199506000-00008.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"777_CR55","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1089\/cap.2005.15.964","volume":"15","author":"JA Staller","year":"2005","unstructured":"Staller JA, Kunwar A, Simionescu M. Oxcarbazepine in the treatment of child psychiatric disorders: a retrospective chart review. J Child Adolesc Psychopharmacol. 2005;15:964\u20139. https:\/\/doi.org\/10.1089\/cap.2005.15.964.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"777_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.655079","volume":"12","author":"TL Pham","year":"2021","unstructured":"Pham TL, Chrousos GP, Merkenschlager A, Petrowski K, Ullmann E. Lamotrigine reduces stress symptoms of chronic anxiety in the times of the Covid-19 natural catastrophe: a case report. Front Psychiatry. 2021;12:655079. https:\/\/doi.org\/10.3389\/fpsyt.2021.655079.","journal-title":"Front Psychiatry"},{"key":"777_CR57","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/01.pra.0000452561.98286.1e","volume":"20","author":"B Green","year":"2014","unstructured":"Green B. Prazosin in the treatment of PTSD. J Psychiatr Pract. 2014;20:253\u20139. https:\/\/doi.org\/10.1097\/01.pra.0000452561.98286.1e.","journal-title":"J Psychiatr Pract"},{"key":"777_CR58","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/01.CHI.0000052509.98293.97","volume":"42","author":"Z Brkanac","year":"2003","unstructured":"Brkanac Z, Pastor JF, Storck M. Prazosin IN PTSD. J Am Acad Child Adolesc Psychiatry. 2003;42:384\u20135. https:\/\/doi.org\/10.1097\/01.CHI.0000052509.98293.97.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"777_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.803220","volume":"13","author":"P Guo","year":"2022","unstructured":"Guo P, Fang Y, Feng M, Zhao X, Wang S, Qian M, et al. Case report: prazosin augmentation for treating comorbid treatment-resistant depression and chronic post-traumatic stress disorder. Front Psychiatry. 2022;13:803220. https:\/\/doi.org\/10.3389\/fpsyt.2022.803220.","journal-title":"Front Psychiatry."},{"key":"777_CR60","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1089\/cap.2012.0035","volume":"22","author":"OO Oluwabusi","year":"2012","unstructured":"Oluwabusi OO, Sedky K, Bennett DS. Prazosin treatment of nightmares and sleep disturbances associated with posttraumatic stress disorder: two adolescent cases. J Child Adolesc Psychopharmacol. 2012;22:399\u2013402. https:\/\/doi.org\/10.1089\/cap.2012.0035.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"777_CR61","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3389\/fpsyt.2020.00724","volume":"11","author":"V Ferrafiat","year":"2020","unstructured":"Ferrafiat V, Soleimani M, Chaumette B, Martinez A, Guil\u00e9 J-M, Keeshin B, et al. Use of prazosin for pediatric post-traumatic stress disorder with nightmares and\/or sleep disorder: case series of 18 patients prospectively assessed. Front Psychiatry. 2020;11:724. https:\/\/doi.org\/10.3389\/fpsyt.2020.00724.","journal-title":"Front Psychiatry."},{"key":"777_CR62","doi-asserted-by":"publisher","first-page":"199","DOI":"10.9740\/mhc.2024.06.199","volume":"14","author":"S Khalid","year":"2024","unstructured":"Khalid S, Mitchell S, Al-Mateen C. Comparison of alpha-2 agonist versus alpha-1 antagonist for post-traumatic stress disorder-associated nightmares in pediatric patients. Ment Health Clin. 2024;14:199\u2013203. https:\/\/doi.org\/10.9740\/mhc.2024.06.199.","journal-title":"Ment Health Clin"},{"key":"777_CR63","doi-asserted-by":"publisher","first-page":"45","DOI":"10.9740\/mhc.2021.03.045","volume":"11","author":"N Hudson","year":"2021","unstructured":"Hudson N, Burghart S, Reynoldson J, Grauer D. Evaluation of low dose prazosin for PTSD-associated nightmares in children and adolescents. Ment Health Clin. 2021;11:45\u20139. https:\/\/doi.org\/10.9740\/mhc.2021.03.045.","journal-title":"Ment Health Clin"},{"key":"777_CR64","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1089\/10445460152595649","volume":"11","author":"MD De Bellis","year":"2001","unstructured":"De Bellis MD, Keshavan MS, Harenski KA. Anterior cingulate N-acetylaspartate\/creatine ratios during clonidine treatment in a maltreated child with posttraumatic stress disorder. J Child Adolesc Psychopharmacol. 2001;11:311\u20136. https:\/\/doi.org\/10.1089\/10445460152595649.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"777_CR65","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1097\/00004583-199609000-00022","volume":"35","author":"RJ Harmon","year":"1996","unstructured":"Harmon RJ, Riggs PD. Clonidine for posttraumatic stress disorder in preschool children. J Am Acad Child Adolesc Psychiatry. 1996;35:1247\u20139. https:\/\/doi.org\/10.1097\/00004583-199609000-00022.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"777_CR66","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1097\/00004583-199608000-00006","volume":"35","author":"JP Horrigan","year":"1996","unstructured":"Horrigan JP. Guanfacine for PTSD nightmares. J Am Acad Child Adolesc Psychiatry. 1996;35:975\u20136. https:\/\/doi.org\/10.1097\/00004583-199608000-00006.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"777_CR67","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1089\/cap.2008.1863","volume":"18","author":"GJ Lyon","year":"2008","unstructured":"Lyon GJ, Coffey B, Silva R. Postraumatic stress disorder and reactive attachment disorder: outcome in an adolescent. J Child Adolesc Psychopharmacol. 2008;18:641\u20136. https:\/\/doi.org\/10.1089\/cap.2008.1863.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"777_CR68","first-page":"253","volume-title":"Catecholamine function in post traumatic stress disorder: emerging concepts","author":"BD Perry","year":"1994","unstructured":"Perry BD. Neurobiological sequelae of childhood trauma: post traumatic stress disorders in children. In: Murburg MM, editor. Catecholamine function in post traumatic stress disorder: emerging concepts. Washington, DC: American Psychiatric Press Inc.; 1994. p. 253\u201376."},{"key":"777_CR69","first-page":"475","volume":"91","author":"DM Porter","year":"1999","unstructured":"Porter DM, Bell CC. The use of clonidine in post-traumatic stress disorder. J Natl Med Assoc. 1999;91:475\u20137.","journal-title":"J Natl Med Assoc"},{"key":"777_CR70","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/ajhp\/zxz021","volume":"76","author":"L Ye","year":"2019","unstructured":"Ye L, Shipley E, Lippmann S. Transdermal clonidine for mitigating posttraumatic stress disorder in an adolescent. Am J Health Syst Pharm. 2019;76:487\u20138. https:\/\/doi.org\/10.1093\/ajhp\/zxz021.","journal-title":"Am J Health Syst Pharm"},{"key":"777_CR71","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1089\/cap.2020.29186.bjc","volume":"30","author":"J Anderson","year":"2020","unstructured":"Anderson J, Wang C, Zaidi A, Rice T, Coffey BJ. Guanfacine as a treatment for posttraumatic stress disorder in an adolescent female. J Child Adolesc Psychopharmacol. 2020;30:398\u2013401. https:\/\/doi.org\/10.1089\/cap.2020.29186.bjc.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"777_CR72","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1089\/cap.2012.0119","volume":"23","author":"DF Connor","year":"2013","unstructured":"Connor DF, Grasso DJ, Slivinsky MD, Pearson GS, Banga A. An open-label study of guanfacine extended release for traumatic stress related symptoms in children and adolescents. J Child Adolesc Psychopharmacol. 2013;23:244\u201351. https:\/\/doi.org\/10.1089\/cap.2012.0119.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"777_CR73","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1089\/cap.2022.29221.bjc","volume":"32","author":"S Wu","year":"2022","unstructured":"Wu S, Morgenstern A, Rice T, Coffey B. Psychopharmacological strategies employing guanfacine in an adolescent girl with postural orthostatic tachycardia syndrome and severe posttraumatic stress disorder. J Child Adolesc Psychopharmacol. 2022;32:244\u20138. https:\/\/doi.org\/10.1089\/cap.2022.29221.bjc.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"777_CR74","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.53009","volume":"16","author":"A Jagtiani","year":"2024","unstructured":"Jagtiani A, Gandhi R, Banga A, Blacker J, Joshi R, Bollu B, et al. Alpha-2 agonists in children and adolescents with post-traumatic stress disorder: a systematic review. Cureus. 2024;16:e53009. https:\/\/doi.org\/10.7759\/cureus.53009.","journal-title":"Cureus"},{"key":"777_CR75","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1001\/archpedi.1988.02150110122036","volume":"142","author":"R Famularo","year":"1988","unstructured":"Famularo R, Kinscherff R, Fenton T. Propranolol treatment for childhood posttraumatic stress disorder, acute type: a pilot study. Am J Dis Child. 1988;142:1244. https:\/\/doi.org\/10.1001\/archpedi.1988.02150110122036.","journal-title":"Am J Dis Child"},{"key":"777_CR76","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1089\/104454604773840490","volume":"14","author":"R Kant","year":"2004","unstructured":"Kant R, Chalansani R, Chengappa KNR, Dieringer MF. The off-label use of clozapine in adolescents with bipolar disorder, intermittent explosive disorder, or posttraumatic stress disorder. J Child Adolesc Psychopharmacol. 2004;14:57\u201363. https:\/\/doi.org\/10.1089\/104454604773840490.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"777_CR77","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/01.jcp.0000186901.79861.e2","volume":"25","author":"S Stathis","year":"2005","unstructured":"Stathis S, Martin G, McKenna JG. A preliminary case series on the use of quetiapine for posttraumatic stress disorder in juveniles within a youth detention center. J Clin Psychopharmacol. 2005;25:539\u201344. https:\/\/doi.org\/10.1097\/01.jcp.0000186901.79861.e2.","journal-title":"J Clin Psychopharmacol"},{"key":"777_CR78","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/JCP.0000000000000627","volume":"37","author":"M Ipci","year":"2017","unstructured":"Ipci M, Inci SB, Akyol Ardi\u00e7 \u00dc, Ercan ES. A case of Asperger syndrome with comorbidity of posttraumatic stress disorder and selective mutism: significant remission with the combination of aripiprazole and eye movement desensitization and reprocessing. J Clin Psychopharmacol. 2017;37:109\u201310. https:\/\/doi.org\/10.1097\/JCP.0000000000000627.","journal-title":"J Clin Psychopharmacol"},{"key":"777_CR79","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1542\/peds.2014-4152","volume":"136","author":"AC Donoghue","year":"2015","unstructured":"Donoghue AC, Roback MG, Cullen KR. Remission from behavioral dysregulation in a child with PTSD after receiving procedural ketamine. Pediatrics. 2015;136:694\u20136. https:\/\/doi.org\/10.1542\/peds.2014-4152.","journal-title":"Pediatrics"},{"key":"777_CR80","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1159\/000348585","volume":"82","author":"T Sasaki","year":"2013","unstructured":"Sasaki T, Hashimoto K, Okawada K, Tone J, Machizawa A, Tano A, et al. Ifenprodil for the treatment of flashbacks in adolescent female posttraumatic stress disorder patients with a history of abuse. Psychother Psychosom. 2013;82:344\u20135. https:\/\/doi.org\/10.1159\/000348585.","journal-title":"Psychother Psychosom"},{"key":"777_CR81","unstructured":"Chao Y-S, McCormack S. Medicinal and synthetic cannabinoids for pediatric patients: a review of clinical effectiveness and guidelines. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK551866\/pdf\/Bookshelf_NBK551866.pdf. Accessed 6 Sept 2026."},{"issue":"2","key":"777_CR82","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1089\/can.2022.0130","volume":"8","author":"NA Lookfong","year":"2023","unstructured":"Lookfong NA, Raup-Konsavage WM, Silberman Y. Potential utility of cannabidiol in stress-related disorders. Cannabis Cannabinoid Res. 2023;8(2):230\u201340. https:\/\/doi.org\/10.1089\/can.2022.0130.","journal-title":"Cannabis Cannabinoid Res"},{"key":"777_CR83","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-1818","volume":"140","author":"SS Wong","year":"2017","unstructured":"Wong SS, Wilens TE. Medical cannabinoids in children and adolescents: a systematic review. Pediatrics. 2017;140:e20171818. https:\/\/doi.org\/10.1542\/peds.2017-1818.","journal-title":"Pediatrics"},{"key":"777_CR84","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1177\/0269881113499207","volume":"27","author":"CG Reich","year":"2013","unstructured":"Reich CG, Iskander AN, Weiss MS. Cannabinoid modulation of chronic mild stress-induced selective enhancement of trace fear conditioning in adolescent rats. J Psychopharmacol. 2013;27:947\u201355. https:\/\/doi.org\/10.1177\/0269881113499207.","journal-title":"J Psychopharmacol"},{"key":"777_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2021.113517","volume":"415","author":"CE Smiley","year":"2021","unstructured":"Smiley CE, Saleh HK, Nimchuk KE, Garcia-Keller C, Gass JT. Adolescent exposure to delta-9-tetrahydrocannabinol and ethanol heightens sensitivity to fear stimuli. Behav Brain Res. 2021;415:113517. https:\/\/doi.org\/10.1016\/j.bbr.2021.113517.","journal-title":"Behav Brain Res"},{"key":"777_CR86","doi-asserted-by":"publisher","first-page":"16","DOI":"10.7812\/TPP\/16-005","volume":"20","author":"S Shannon","year":"2016","unstructured":"Shannon S, Opila-Lehman J. Effectiveness of cannabidiol oil for pediatric anxiety and insomnia as part of posttraumatic stress disorder: a case report. Perm J. 2016;20:16\u2013005. https:\/\/doi.org\/10.7812\/TPP\/16-005.","journal-title":"Perm J."},{"key":"777_CR87","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s11920-024-01577-2","volume":"27","author":"J Geller","year":"2025","unstructured":"Geller J, Whitney E. Therapeutic potential of MDMA- and psychedelic-assisted psychotherapy for adolescent depression and trauma. Curr Psychiatry Rep. 2025;27:88\u201397. https:\/\/doi.org\/10.1007\/s11920-024-01577-2.","journal-title":"Curr Psychiatry Rep"},{"key":"777_CR88","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1353\/pbm.2023.0007","volume":"66","author":"GA Edelsohn","year":"2023","unstructured":"Edelsohn GA, Sisti D. Past is prologue: ethical issues in pediatric psychedelics research and treatment. Perspect Biol Med. 2023;66:129\u201344. https:\/\/doi.org\/10.1353\/pbm.2023.0007.","journal-title":"Perspect Biol Med"},{"key":"777_CR89","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1089\/cap.2024.0082","volume":"35","author":"I Sutherland","year":"2025","unstructured":"Sutherland I, Ho M-F, Croarkin PE. Psychedelic treatments in adolescent psychopharmacology: considering safety, ethics, and scientific rigor. J Child Adolesc Psychopharmacol. 2025;35:118\u201325. https:\/\/doi.org\/10.1089\/cap.2024.0082.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"777_CR90","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.jaac.2024.03.021","volume":"63","author":"JK Jeffrey","year":"2024","unstructured":"Jeffrey JK, Weintraud MJ, Grob CS. Clinical research trials of psychedelic-assisted therapy in adolescents aged 16 to 17 years: rationale balanced with caution. J Am Acad Child Adolesc Psychiatry. 2024;63:1196\u20138. https:\/\/doi.org\/10.1016\/j.jaac.2024.03.021.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"777_CR91","doi-asserted-by":"publisher","DOI":"10.1186\/1753-2000-6-15","volume":"6","author":"E Gospodarevskaya","year":"2012","unstructured":"Gospodarevskaya E, Segal L. Cost-utility analysis of different treatments for post-traumatic stress disorder in sexually abused children. Child Adolesc Psychiatry Ment Health. 2012;6:15. https:\/\/doi.org\/10.1186\/1753-2000-6-15.","journal-title":"Child Adolesc Psychiatry Ment Health"},{"key":"777_CR92","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1089\/cap.2013.0106","volume":"24","author":"MS Scheeringa","year":"2014","unstructured":"Scheeringa MS, Weems CF. Randomized placebo-controlled D-cycloserine with cognitive behavior therapy for pediatric posttraumatic stress. J Child Adolesc Psychopharmacol. 2014;24:69\u201377. https:\/\/doi.org\/10.1089\/cap.2013.0106.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"777_CR93","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cpr.2016.05.006","volume":"47","author":"N Morina","year":"2016","unstructured":"Morina N, Koerssen R, Pollet TV. Interventions for children and adolescents with posttraumatic stress disorder: a meta-analysis of comparative outcome studies. Clin Psychol Rev. 2016;47:41\u201354. https:\/\/doi.org\/10.1016\/j.cpr.2016.05.006.","journal-title":"Clin Psychol Rev"},{"key":"777_CR94","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/15622975.2022.2086295","volume":"24","author":"B Bandelow","year":"2023","unstructured":"Bandelow B, Allgulander C, Baldwin DS, Costa DLDC, Denys D, Dilbaz N, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders\u2014version 3. Part I: anxiety disorders. World J Biol Psychiatry. 2023;24:79\u2013117. https:\/\/doi.org\/10.1080\/15622975.2022.2086295.","journal-title":"World J Biol Psychiatry."},{"key":"777_CR95","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1176\/appi.ajp.161.6.1079","volume":"161","author":"KD Wagner","year":"2004","unstructured":"Wagner KD, Robb AS, Findling RL, Jin J, Gutierrez MM, Heydorn WE. A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. Am J Psychiatry. 2004;161:1079\u201383. https:\/\/doi.org\/10.1176\/appi.ajp.161.6.1079.","journal-title":"Am J Psychiatry"},{"key":"777_CR96","doi-asserted-by":"publisher","DOI":"10.1080\/20008066.2025.2474375","volume":"16","author":"J Rolling","year":"2025","unstructured":"Rolling J, Reynaud E, Mengin AC, Zanfonato T, Bourgin P, Schroder CM. Protocol MelatoSom-Kids-PTSD: sleep disturbances in children and adolescents with post-traumatic stress disorder (PTSD): a randomized double-blind placebo-controlled trial to investigate the efficacy of paediatric prolonged-release melatonin. Eur J Psychotraumatol. 2025;16:2474375. https:\/\/doi.org\/10.1080\/20008066.2025.2474375.","journal-title":"Eur J Psychotraumatol"},{"key":"777_CR97","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/s0006-3223(99)00044-x","volume":"45","author":"MDD Bellis","year":"1999","unstructured":"Bellis MDD, Baum AS, Birmaher B, Keshavan MS, Eccard CH, Boring AM, et al. A. E. Bennett Research Award Developmental Traumatology Part I: biological stress systems. Biol Psychiatry. 1999;45:1259\u201370. https:\/\/doi.org\/10.1016\/s0006-3223(99)00044-x.","journal-title":"Biol Psychiatry"},{"key":"777_CR98","doi-asserted-by":"publisher","DOI":"10.1186\/s11689-020-09337-y","volume":"12","author":"KE Smith","year":"2020","unstructured":"Smith KE, Pollak SD. Early life stress and development: potential mechanisms for adverse outcomes. J Neurodev Disord. 2020;12:34. https:\/\/doi.org\/10.1186\/s11689-020-09337-y.","journal-title":"J Neurodev Disord"},{"key":"777_CR99","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1186\/s12888-024-06093-4","volume":"24","author":"M Riou","year":"2024","unstructured":"Riou M, Duclos H, Leribillard M, Parienti J-J, Segobin S, Viard A, et al. Borderline personality disorder and post-traumatic stress disorder in adolescents: protocol for a comparative study of borderline personality disorder with and without comorbid post-traumatic stress disorder (BORDERSTRESS-ADO). BMC Psychiatry. 2024;24:724. https:\/\/doi.org\/10.1186\/s12888-024-06093-4.","journal-title":"BMC Psychiatry"},{"key":"777_CR100","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3371\/CSRP.ABOU.123015","volume":"12","author":"W Abdelghaffar","year":"2018","unstructured":"Abdelghaffar W, Ouali U, Jomli R, Zgueb Y, Nacef F. Posttraumatic stress disorder in first-episode psychosis: prevalence and related factors. Clin Schizophr Relat Psychoses. 2018;12:105\u201312. https:\/\/doi.org\/10.3371\/CSRP.ABOU.123015.","journal-title":"Clin Schizophr Relat Psychoses"},{"key":"777_CR101","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.psyneuen.2004.06.004","volume":"30","author":"DL Delahanty","year":"2005","unstructured":"Delahanty DL, Nugent NR, Christopher NC, Walsh M. Initial urinary epinephrine and cortisol levels predict acute PTSD symptoms in child trauma victims. Psychoneuroendocrinology. 2005;30:121\u20138. https:\/\/doi.org\/10.1016\/j.psyneuen.2004.06.004.","journal-title":"Psychoneuroendocrinology"},{"key":"777_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2024.100849","volume":"41","author":"S Lawrence","year":"2024","unstructured":"Lawrence S, Scofield RH. Post traumatic stress disorder associated hypothalamic\u2013pituitary\u2013adrenal axis dysregulation and physical illness. Brain Behav Immun Health. 2024;41:100849. https:\/\/doi.org\/10.1016\/j.bbih.2024.100849.","journal-title":"Brain Behav Immun Health."},{"key":"777_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2019.112342","volume":"379","author":"M-D Wei","year":"2020","unstructured":"Wei M-D, Wang Y-H, Lu K, Lv B-J, Wang Y, Chen W-Y. Ketamine reverses the impaired fear memory extinction and accompanied depressive-like behaviors in adolescent mice. Behav Brain Res. 2020;379:112342. https:\/\/doi.org\/10.1016\/j.bbr.2019.112342.","journal-title":"Behav Brain Res"},{"key":"777_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2025.119859","author":"J Xu","year":"2025","unstructured":"Xu J, Zhang Y, Wang X, Xu W, Chen S, Pan L, et al. A P2X7 receptor antagonist alleviates PTSD-like behaviors in adolescent rats through gut microbiota modulation and hippocampal transcriptomic remodeling. J Affect Disord. 2025. https:\/\/doi.org\/10.1016\/j.jad.2025.119859.","journal-title":"J Affect Disord"},{"key":"777_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12183-z","volume":"7","author":"D Hu","year":"2017","unstructured":"Hu D, Yu Z-L, Zhang Y, Han Y, Zhang W, Lu L, et al. Bumetanide treatment during early development rescues maternal separation-induced susceptibility to stress. Sci Rep. 2017;7:11878. https:\/\/doi.org\/10.1038\/s41598-017-12183-z.","journal-title":"Sci Rep"},{"key":"777_CR106","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24031941","volume":"24","author":"P Grochecki","year":"2023","unstructured":"Grochecki P, Smaga I, Wydra K, Marszalek-Grabska M, Slowik T, Kedzierska E, et al. Impact of mephedrone on fear memory in adolescent rats: involvement of matrix metalloproteinase-9 (MMP-9) and N-methyl-D-aspartate (NMDA) receptor. Int J Mol Sci. 2023;24:1941. https:\/\/doi.org\/10.3390\/ijms24031941.","journal-title":"Int J Mol Sci"},{"key":"777_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.178256","volume":"1007","author":"L Fu","year":"2025","unstructured":"Fu L, Wenbin X, Lijuan T, Rongrong S, Rongrong Y, Wenfeng H, et al. Monophosphoryl lipid A induces tolerance against single prolonged stress-induced PTSD-like behavior and neuroinflammatory responses in mice. Eur J Pharmacol. 2025;1007:178256. https:\/\/doi.org\/10.1016\/j.ejphar.2025.178256.","journal-title":"Eur J Pharmacol"},{"key":"777_CR108","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1684\/epd.2013.0574","volume":"15","author":"T Sasaki","year":"2013","unstructured":"Sasaki T, Kodaka F, Taniguchi G, Nishikawa T, Watanabe M. Experiential auditory hallucinations due to chronic epileptic discharges after radiotherapy for oligoastrocytoma. Epileptic Disord. 2013;15:188\u201392. https:\/\/doi.org\/10.1684\/epd.2013.0574.","journal-title":"Epileptic Disord"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-026-00777-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40272-026-00777-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-026-00777-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:03:33Z","timestamp":1793923413000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40272-026-00777-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":108,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["777"],"URL":"https:\/\/doi.org\/10.1007\/s40272-026-00777-y","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]},"assertion":[{"value":"16 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CT and HK have no conflicts of interest that are directly relevant to the content of this article. EB reports speaking or consulting fees from Johnson & Johnson and Cerevel Therapeutics LLC, and licenses or royalties from Springer and Wolters Kluwer. JR reports royalties from Dunod.","order":1,"name":"Ethics","label":"Conflicts of interest\/competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Because of the methodology of this article, a literature review, no request for evaluation by an ethics committee was necessary.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Because of the methodology of this article, a literature review, no request for informed consent to participate was necessary.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Because of the methodology of this article, a literature review, no request for informed consent to publish was necessary.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All of these data are taken from the articles cited in our bibliography, which are sourced from the PubMed database.","order":5,"name":"Ethics","label":"Availability of data and material","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":6,"name":"Ethics","label":"Code availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"CT performed the search, screening, full text assessment, data extraction and analysis, and wrote the article. HK set the objectives and methodology for this study, and proofread and edited the article. EB proofread and edited the article. JR performed the search, screening and supervision (of the full-text assessment, the data extraction and analysis, and the writing of the article), and proofread and edited the article. All authors read and approved the final submitted manuscript.","order":7,"name":"Ethics","label":"Authors\u2019 contributions","group":{"name":"EthicsHeading","label":"Declarations"}}]}}